RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 132 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $25,941 | +1.7% | 17,528 | 0.0% | 0.00% | – |
Q4 2023 | $25,503 | +26.3% | 17,528 | -6.2% | 0.00% | – |
Q3 2023 | $20,189 | -24.5% | 18,693 | -9.8% | 0.00% | – |
Q2 2023 | $26,725 | -6.5% | 20,717 | -4.4% | 0.00% | – |
Q1 2023 | $28,591 | -12.3% | 21,660 | 0.0% | 0.00% | – |
Q4 2022 | $32,598 | -57.1% | 21,660 | -66.2% | 0.00% | – |
Q3 2022 | $76,000 | +7.0% | 64,114 | +2.3% | 0.00% | – |
Q2 2022 | $71,000 | -64.7% | 62,642 | -6.8% | 0.00% | – |
Q1 2022 | $201,000 | +12.3% | 67,224 | +0.0% | 0.00% | – |
Q4 2021 | $179,000 | -21.8% | 67,210 | +6.6% | 0.00% | – |
Q3 2021 | $229,000 | +77.5% | 63,054 | +112.6% | 0.00% | – |
Q2 2021 | $129,000 | +35.8% | 29,657 | +7.2% | 0.00% | – |
Q1 2021 | $95,000 | +14.5% | 27,663 | +16.3% | 0.00% | – |
Q4 2020 | $83,000 | +45.6% | 23,796 | 0.0% | 0.00% | – |
Q3 2020 | $57,000 | 0.0% | 23,796 | -23.6% | 0.00% | – |
Q2 2020 | $57,000 | +29.5% | 31,149 | +10.6% | 0.00% | – |
Q1 2020 | $44,000 | -43.6% | 28,153 | -22.1% | 0.00% | – |
Q4 2019 | $78,000 | +36.8% | 36,143 | +19.7% | 0.00% | – |
Q3 2019 | $57,000 | -27.8% | 30,192 | 0.0% | 0.00% | – |
Q2 2019 | $79,000 | +1.3% | 30,192 | 0.0% | 0.00% | – |
Q1 2019 | $78,000 | +13.0% | 30,192 | 0.0% | 0.00% | – |
Q4 2018 | $69,000 | -22.5% | 30,192 | +9.0% | 0.00% | – |
Q3 2018 | $89,000 | +12.7% | 27,692 | 0.0% | 0.00% | – |
Q2 2018 | $79,000 | -15.1% | 27,692 | +5.4% | 0.00% | – |
Q1 2018 | $93,000 | -32.1% | 26,273 | -26.3% | 0.00% | – |
Q4 2017 | $137,000 | +80.3% | 35,649 | +16.5% | 0.00% | – |
Q3 2017 | $76,000 | -9.5% | 30,605 | 0.0% | 0.00% | – |
Q2 2017 | $84,000 | -4.5% | 30,605 | +15.8% | 0.00% | – |
Q1 2017 | $88,000 | +33.3% | 26,431 | -3.8% | 0.00% | – |
Q4 2016 | $66,000 | +22.2% | 27,485 | +79.6% | 0.00% | – |
Q3 2016 | $54,000 | +45.9% | 15,302 | -11.6% | 0.00% | – |
Q2 2016 | $37,000 | +5.7% | 17,309 | 0.0% | 0.00% | – |
Q1 2016 | $35,000 | -34.0% | 17,309 | 0.0% | 0.00% | – |
Q4 2015 | $53,000 | +26.2% | 17,309 | 0.0% | 0.00% | – |
Q3 2015 | $42,000 | -19.2% | 17,309 | 0.0% | 0.00% | – |
Q2 2015 | $52,000 | -16.1% | 17,309 | 0.0% | 0.00% | – |
Q1 2015 | $62,000 | +55.0% | 17,309 | 0.0% | 0.00% | – |
Q4 2014 | $40,000 | +14.3% | 17,309 | 0.0% | 0.00% | – |
Q3 2014 | $35,000 | – | 17,309 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |